Quarterly report pursuant to Section 13 or 15(d)

RESTRUCTURING CHARGES (Tables)

v3.23.1
RESTRUCTURING CHARGES (Tables)
3 Months Ended
Mar. 31, 2023
RESTRUCTURING CHARGES.  
Schedule of employee severance, benefits and related costs

During the three months ended March 31, 2023, the Company recorded the following activity related to the Initiative in accrued expenses and other current liabilities on the balance sheet (in thousands):

Three Months Ended March 31, 

2023

2022

Accrued expenses, beginning of period

$

1,096

$

Restructuring charges

3,618

Cash payments

(1,164)

Inventory write-off

(300)

Accrued expenses, end of period

$

3,250

$

Schedule of restructuring and related costs

During the three months ended March 31, 2023, the Company recorded restructuring charges of $3.6 million related to employee severance, benefits and related costs, inventory write-offs, royalty expenses associated with discontinued product offerings, and facility consolidations which were expensed as follows (in thousands):

Three Months Ended March 31, 

2023

2022

Cost of sales

$

717

$

Research and development

2,633

Sales and marketing

126

General and administrative

 

142

 

Total restructuring charges

$

3,618

$